A Possible Cure for Refractory DLBCL: CARs Are Headed in the Right Direction

Julio C. Chavez; Frederick L. Locke

首页> 外文期刊>Molecular therapy: the journal of the American Society of Gene Therapy >A Possible Cure for Refractory DLBCL: CARs Are Headed in the Right Direction

【24h】

A Possible Cure for Refractory DLBCL: CARs Are Headed in the Right Direction

机译：可能为难治性DLBCL治愈：汽车朝着正确的方向前进

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Molecular therapy: the journal of the American Society of Gene Therapy》 |2017年第10期|共3页
作者
Julio C. Chavez; Frederick L. Locke;
展开▼
作者单位

Department of Malignant Hematology Moffitt Cancer Center Tampa FL USA;

Department of Blood and Marrow Transplant and Cellular Immunotherapy Moffitt Cancer Center Tampa;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类治疗学;
关键词

相似文献

外文文献
中文文献
专利

1. A Possible Cure for Refractory DLBCL: CARs Are Headed in the Right Direction [J] . Julio C. Chavez, Frederick L. Locke Molecular therapy: the journal of the American Society of Gene Therapy . 2017,第10期

机译：可能为难治性DLBCL治愈：汽车朝着正确的方向前进
2. Therapeutic effects of chimeric antigen receptor T cells (CAR-T) on relapse/refractory diffuse large B-cell lymphoma (R/R DLBCL): a meta-analysis [J] . H.-H. Cao, L.-L. Wang, C.-K. Geng, European review for medical and pharmacological sciences. . 2020,第9期

机译：嵌合抗原受体T细胞（CAR-T）对复发/耐火弥漫性大B细胞淋巴瘤（R / R DLBCL）的治疗作用（R / R DLBCL）：荟萃分析
3. Evaluation of In Vivo CAR Transgene Levels in Relapsed/Refractory Pediatric and Young Adult ALL and Adult DLBCL Tisagenlecleucel-Treated Patients [J] . Awasthi Rakesh, Mueller Karen Thudium, Yanik Gregory A., Blood: The Journal of the American Society of Hematology . 2018,第NovaelaTreatmentAppr期

机译：对复发/难治性儿科和年轻成人的体内汽车转基因水平的评价和成人DLBCL的Tisagenleclecle治疗患者
4. TOTAL CURE SHRINKAGE OF CARBON-EPOXY COMPOSITES IN THREE PRINCIPAL DIRECTIONS [C] . R. Das, B. Tavakol, A. Ahmed, SAMPE conference and exhibition . 2011

机译：三个主要方向上碳-环氧树脂复合材料的总固化收缩率
5. Safety and Efficacy of the Immunomodulatory Drug (IMiD) Lenalidomide in Patients with Lymphoma: Development of RU051417I - Phase I/II Open-Label Study of R-ICE (Rituximab-Ifosfamide-Carboplatin-Etoposide) with Lenalidomide [R2-ICE] in Patients with First-Relapse/Primary Refractory Diffuse Large B-Cell Lymphoma (DLBCL). [D] . Kasi, Pashtoon Murtaza. 2018

机译：免疫调节药物来那度胺在淋巴瘤患者中的安全性和有效性：RU051417I-R-ICE（利妥昔单抗-异环磷酰胺-卡铂-依托泊苷）与来那度胺[R2-ICE]的I / II期开放标签研究的进展初次复发/原发性难治性弥漫性大B细胞淋巴瘤（DLBCL）。
6. A Possible Cure for Refractory DLBCL: CARs Are Headed in the Right Direction [O] . Julio C. Chavez, Frederick L. Locke 2017

机译：难治性DLBCL的可能治愈方法：汽车走向正确的方向
7. A Possible Cure for Refractory DLBCL: CARs Are Headed in the Right Direction [O] . Julio C. Chavez, Frederick L. Locke 2017

机译：可能为难治性DLBCL治愈：汽车朝着正确的方向前进
8. Evaluation of epoxy cured with Ethacure 100 curing agent for use in headers for thermal batteries. [R] . Guidotti, R. A., Wells, B. J. 1992

机译：评估用Ethacure 100固化剂固化的环氧树脂，用于热电池的集管。

A Possible Cure for Refractory DLBCL: CARs Are Headed in the Right Direction

著录项

相似文献

相关主题

期刊订阅